Fierce Pharma

JANUARY 11, 2024

Dermavant’s topical cream Vtama, already on the market for plaque psoriasis as a steroid-free treatment, is compiling impressive data in pursuit of an FDA approval in atopic dermatitis (AD). | Dermavant’s topical cream Vtama, already on the market for plaque psoriasis as a steroid-free treatment, is compiling impressive data in pursuit of an FDA approval in atopic dermatitis (AD).

FDA 301

FDA Marketing 301

PharmaVoice

JANUARY 11, 2024

As advanced therapies and patient perspectives strengthen their foothold in R&D, pharma is poised to deliver impactful treatments in record time.

Pharma 131

Pharma Patients 131

Fierce Pharma

JANUARY 11, 2024

With sales declining for aging MS drug Fampyra, Biogen has exercised an option to return licensing rights outside of the U.S. to Acorda Therapeutics.

Sales 282

Sales 282

European Pharmaceutical Review

JANUARY 11, 2024

The European Commission (EC) has granted a marketing authorisation for Uzpruvo ® (AVT04) in Europe, a biosimilar candidate to Stelara ® (ustekinumab). Ustekinumab biologic Once the European Supplementary Protection Certificate (SPC) for Stelara expires in July 2024, this will open up market entry as soon as possible for Uzpruvo, now that it is approved in Europe” Ustekinumab is a human IgG1κ monoclonal antibody (mAb).

Competition 115

Competition Marketing Safety Manufacturing 115

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JANUARY 11, 2024

Pfizer is still hungry for ADC opportunities, including in the Far East. | Pfizer mused on ADC opportunities in China, while Takeda's R&D head revealed details behind the company's competitive TYK2 deal with Nimbus at this year's J.P. Morgan Healthcare Conference. Astellas received a manufacturing-related rejection for its gastric cancer candidate.

Competition 130

Competition Pharma Manufacturing Healthcare 130

MedCity News

JANUARY 11, 2024

At CES 2024, menopause startup Amira launched The Terra System, a wearable cooling device that supports women battling hot flashes and helps them sleep through the night.

120

120

MedCity News

JANUARY 11, 2024

Generic competition has eroded sales of multiple sclerosis drug Ampyra, marketed as Fampyra outside the U.S. Biogen told Acorda Therapeutics that it’s terminating its ex-U.S. rights to Fampyra in order to focus on other priorities, which include expanding beyond MS.

Competition 112

Competition Sales Marketing Biopharma 112

European Pharmaceutical Review

JANUARY 11, 2024

chronic neuropathic pain is at present, mainly managed with antidepressants… antiepileptic drugs… as well as opioids” Neuropathic pain affects over 400 million people worldwide, according to Hoba Therapeutics. In Europe, the prevalence of chronic neuropathic pain is estimated to be six–eight percent 1 of the general population. Drug development for pain management is “incredibly complex… mainly because the trials are so challenging to conduct”, the company highlight

Medicine 102

Medicine Pharmacology Management Side effects 102

MedCity News

JANUARY 11, 2024

This year’s J.P. Morgan Healthcare Conference brought a bevy of news announcements — from acquisitions to partnerships to new products and more. This list compiles short summaries for seven of the event’s most notable announcements.

Healthcare 110

Healthcare Healthcare Biopharma 110

European Pharmaceutical Review

JANUARY 11, 2024

Researchers at the Institute for Molecular Science in Japan have successfully observed vibrational spectra of single proteins using infrared nanospectroscopy. The observations made consisted of ~500 amino acid residues, using advanced measurement techniques based on near-field optical microscopy. Comparatively, this method is a challenge with conventional infrared spectroscopy.

Leads 98

Leads Pharmaceutical 98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JANUARY 11, 2024

The hospital sector’s financial performance in November showed signs of continued stabilization and growth, according to Kaufman Hall’s latest monthly report. Hospitals should “take advantage of the relative stability and re-embrace strategic growth if they hope to see continued success in 2024,” stated Erik Swanson, one of the report’s authors.

Marketing 108

Marketing 108

European Pharmaceutical Review

JANUARY 11, 2024

ACC pioneered LAL testing methodology and was the first FDA-licensed company to manufacture LAL reagents. Throughout the years it has grown to be an internationally recognised leader in endotoxin detection. In 2021, they introduced the first commercially available sustainable bacterial endotoxin testing (BET) recombinant Cascade Reagent (rCR), PyroSmart NextGen®.

Manufacturing 95

Manufacturing FDA Pharmaceutical 95

MedCity News

JANUARY 11, 2024

The FDA has found no clear relationship between GLP-1 drugs, such as Ozempic and Mounjaro, and reports of suicidal thoughts or actions. But the agency added that it can’t definitively rule out the risk, and its review is ongoing.

FDA 108

FDA Safety Biopharma Pharma 108

pharmaphorum

JANUARY 11, 2024

Stada and Alvotech get EU approval for first biosimilar of Johnson & Johnson's Stelara in psoriasis, psoriatic arthritis and Crohn's disease indications

98

98

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

JANUARY 11, 2024

This year, ViVE will celebrate nurses throughout the event’s programming, highlighting how their role has evolved, the challenges they face and how they are spurring innovation in different models of care. The event is powered by HLTH and the College of Healthcare Information Management Executives (CHIME).

Healthcare 108

Healthcare Healthcare Management 108

pharmaphorum

JANUARY 11, 2024

NICE has extended the NHS availability of Pfizer’s COVID-19 drug Paxlovid as millions of doses approach their expiry date

104

104

PharmaTimes

JANUARY 11, 2024

The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser

107

107

pharmaphorum

JANUARY 11, 2024

CHMP has called in expert advisors to assist in the review of Eisai and Biogen’s Alzheimer's therapy Leqembi

105

105

Advertisement

PharmaTimes

JANUARY 11, 2024

In 2022, around 8% of patients survived 30 days after a cardiac arrest

Patients 102

Patients 102

pharmaphorum

JANUARY 11, 2024

FDA has authorised imports from France of a life-saving antibiotic for syphilis that is in short supply in the domestic market

FDA 96

FDA Marketing 96

Clarivate

JANUARY 11, 2024

At Clarivate TM , our mission is to advance the success of people and organizations through transformative intelligence and trusted partnership. We are proud to spotlight our women IP experts, whose professionalism and talent make up the core fabric of our endeavour. Continuing this blog series, we present Katie Clapham, Senior Director of IP Partnerships at Clarivate.

Specialization 59

Specialization 59

PharmaTech

JANUARY 11, 2024

Pluri has launched PluriCDMO, a new contract development and manufacturing organization business that will offer cell therapy manufacturing services.

Manufacturing 59

Manufacturing 59

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

ALULA

JANUARY 11, 2024

At ALULA, our love for animal s isn't just a quirk— it's a shared bond that shapes our culture. Although we focus on the human side of business, our shared affection for furry, winged, speckled, or finned friends is strong , and it creates a unique camaraderie. Given this common bond, we can’t pass up the opportunity to celebrate National Dress-Up Your Pet Day this January 14!

52

52

Rep-Lite

JANUARY 11, 2024

A Clinical sales specialist in medical sales is a professional in the healthcare industry who plays a crucial role in promoting and selling medical and healthcare products or services to healthcare providers, such as hospitals, clinics, and private practices. They act as a bridge between healthcare providers and the companies that manufacture or distribute healthcare products, ensuring healthcare professionals have access to the latest and most effective medical technologies and solutions.

Sales 52

Sales Healthcare Healthcare Medical sales 52

Clarify Health

JANUARY 11, 2024

The managed care team at an academic medical center (AMC) in the northeast was preparing for negotiations with a payer partner. The challenge was they first needed to better understand the competitive landscape with insights into other health systems to figure out where they had the best opportunity to secure more favorable rates. Unfortunately, they were challenged with a lack of competitive rate insights outside of their health system, leaving them to rely on historical negotiation tactics and

Medical 52

Medical Competition Management Leads 52

Pharmaceutical Commerce

JANUARY 11, 2024

SELLAS Life Sciences Group, Inc’s CDK9 inhibitor SLS009 is being evaluated in combination with Venclexta (venetoclax) and Vidaza (azacytidine) for patients with relapsed or refractory acute myeloid leukemia.

FDA 52

FDA Patients 52

Advertisement

Distribution

PharmExec

JANUARY 11, 2024

Best practices for defending against lawsuits based on pharmaceutical labeling, including avenues for early resolution of the case and, as necessary, strategies for developing the best evidence for defense.

Pharmaceutical 52

Pharmaceutical 52

Impetus Digital

JANUARY 11, 2024

This is a guest article and does not necessarily reflect the views and values of Impetus Digital. The pharmaceutical industry is an important sector that we all rely on to keep us safe and maintain a good level of health. But with thousands of private and confidential records being stored digitally, the pharma industry can unfortunately fall victim to cybercrime, just as any other online business can.

Pharma 52

Pharma Training Pharmaceutical Consulting 52

PharmExec

JANUARY 11, 2024

SELLAS Life Sciences Group, Inc’s CDK9 inhibitor SLS009 is being evaluated in an ongoing Phase I/II study in combination with Venclexta and Vidaza for patients with relapsed or refractory acute myeloid leukemia.

FDA 52

FDA Patients 52

Pharmaceutical Technology

JANUARY 11, 2024

Innovent has reported positive Phase III results for mazdutide, Eli Lilly’s next-generation obesity asset that Innovent is developing as part of a 2019 deal with the company where it secured the rights to the dual glucagon-like peptide-1 (GLP-1) glucagon receptor agonist.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales